Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05454124
Other study ID # 300006197 (Study 2)
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 1, 2022
Est. completion date November 2025

Study information

Verified date February 2024
Source University of Alabama at Birmingham
Contact Rachel A Chua, MS
Phone 205-410-4041
Email r2chel@uab.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A greater understanding of plasticity after central vision loss can inform new therapies for treating low vision and has the potential to benefit millions of individuals suffering from low vision. The treatment of low vision is particularly relevant to the mission of the NEI to support research on visual disorders, mechanisms of visual function, and preservation of sight. The comparison of different training and outcome factors is in line with the NIMH RDOC framework and studies in an aging population are consistent with the mission of the NIA.


Description:

Research on perceptual learning (PL) has been dominated by studies that seek to isolate and improve individual visual processes. However, an important translational outcome of PL research is to address the needs of patients with vision loss, who seek to improve performance on daily tasks such as reading, navigation, and face recognition. These more ecological cases of behavioral change and cortical plasticity, which are inherently complex and integrative, have revealed significant gaps in a more holistic understanding of how multiple visual processes and their associated brain systems jointly contribute to durable and generalizable PL. To address these gaps, here the investigators study simulated and natural central vision loss. The investigators focus on macular degeneration (MD), one of the most common causes of vision loss (projected to affect 248 million people worldwide by 2040), which results from damage to photoreceptors in the macula that disrupts central vision. Such central vision loss is a superb lens through which study to how ecologically relevant changes in the use of vision relate to changing brain activity and connectivity because it represents a massive alteration in visual experience requiring reliance on peripheral vision for daily tasks. With the use of eye-trackers and gaze-contingent displays that induce central scotomas, central vision loss can be simulated in normally seeing individuals, who then develop peripheral looking patterns that resemble compensatory vision strategies seen in MD patients. Ideal use of peripheral vision requires improvement in multiple vision domains, three of the most important being: early visual processing (e.g., visual sensitivity), mid-level visual processing (e.g., spatial integration), and attention and eye-movements. To date, no study has systematically investigated these three domains of PL and their neural underpinnings. The proposed research plan rests on rigorous prior work showing that PL influences multiple brain structures and functions related to these three domains. The investigators propose a novel approach of systematically measuring how different training regimes related to the three domains influence a broad range of psychophysical and ecological behaviors (Aim 1), how these changes arise from plasticity in brain structure and function (Aim 2), and how PL after simulated central vision loss compares to PL in MD (Aim 3). This work is significant and innovative as it will be the first integrated study of PL characterizing multiple trainable factors and their impact on diverse behavioral outcomes and on cutting-edge assessments of neural representations and dynamics. It is also the first study to directly compare PL in MD patients with PL in a controlled model system of central visual field loss with simulated scotomas, which if validated will allow the use of this model system to interrogate MD in larger samples of healthy individuals. The investigators will also share a unique dataset that will help the field to understand behavioral and neural plasticity after central vision loss and individual differences in responsiveness to training. Finally, this work will illuminate basic mechanisms of brain plasticity after sensory loss that may generalize to other forms of rehabilitation after peripheral or central damage.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date November 2025
Est. primary completion date November 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 89 Years
Eligibility Inclusion Criteria: - Aged 18-89 - Severely impaired vision in both eyes (20/100 or worse) - diagnosis of Macular Degeneration by an Ophthalmologist - Light sensitivity in the macular retina that is at least 10 dB units worse than in peripheral regions, as demonstrated by a scanning laser ophthalmoscope (MAIA) - Medical record review indicating this level of disease severity has been present for at least 2 years - Reside within 50 miles of study site Exclusion Criteria: - Pacemaker or any ferromagnetic metal implanted in their body - Metal of any type implanted in their head (limited dental work is acceptable) - Claustrophobia - Being hearing-impaired - Weight over 300 pounds - Maximum body girth over 60 inches - Previous serious head injury - Presence of hallucinations or delusions - Excessive old, or colorful tattoos, especially near the head - Pregnancy - Braces/permanent retainer

Study Design


Intervention

Behavioral:
Training visual sensitivity
Investigators adopt a standard PL approach to train early visual processes of discriminating the orientation of Gabor patches presented at threshold contrast. Across training blocks, Gabors will range in spatial frequency, where contrast is adapted with a 3/1 staircase. Whenever a specific contrast threshold is reached, spatial frequency will increase by 2 cycles per degree and contrast will be reset. Preliminary data from this method in normally seeing and MD participants show both feasibility and tentative evidence that this training gives rise to improvements in acuity.
Combination training
Daily tasks involve a combination of being sensitive to basic visual features, being able to integrate these features, and directing attention and eye movements to better evaluate the information of potential interest. To address this integrative nature of real-world vision, this condition combines elements of training visual sensitivity, spatial integration, and spatial attention.

Locations

Country Name City State
United States UAB Birmingham Alabama

Sponsors (2)

Lead Sponsor Collaborator
University of Alabama at Birmingham University of California, Riverside

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Change from Baseline Acuity after Completion of Training at approximately 7 weeks Acuity threshold from the Landolt C task. Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Other Change from Baseline Contrast Sensitivity after Completion of Training at approximately 7 weeks Threshold value from contrast sensitivity task. Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Other Change from Baseline Minimal print size from the MNREAD task after Completion of Training at approximately 7 weeks Minimal print size from the MNREAD task Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Other Change from Baseline Precision of Reconstructed Representation of Stimulus Orientation after Completion of Training at approximately 7 weeks Precision of reconstructed representation of stimulus orientation (quantified with FWHM) Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Other Change from Baseline Population receptive field size in V1, V2 and V3 representations of URL and PRL after Completion of Training at approximately 7 weeks Population receptive field size in V1, V2 and V3 representations of URL and PRL (quantified as PRF sigma in the swath of cortex associated with that retinal location). Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Other Change from Baseline Cortical thickness in V1, V2 and V3 representations of the PRL and URL after Completion of Training at approximately 7 weeks Cortical thickness in V1, V2 and V3 representations of the PRL and URL (quantified as mm of cortical thickness) Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Other Change from Baseline Orientation jitter threshold in the contour integration task at PRL or URL after Completion of Training at approximately 7 weeks Orientation jitter threshold in the contour integration task (quantified as threshold average jitter) at PRL or URL. Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Other Change from Baseline Crowding Threshold after Completion of Training at approximately 7 weeks In the contour integration task stimuli are untrained contours of alphanumeric characters made of Gabor elements. This test allows us to estimate how the magnitude of crowding may change at the PRL compared to the non-PRL. Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Other Change from Baseline Decoding classification accuracy for an attended character after Completion of Training at approximately 7 weeks Decoding classification accuracy for an attended character, based on decoding from MRI data within VWFA and LOC regions of interest. Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Other Change from Baseline Strength of background connectivity between areas with larger receptive fields (V4) to the smaller receptive fields contributing information to that area. after Completion of Training at approximately 7 weeks This is measured as functional connectivity (z-transformed Pearson's r) between voxels in V1 to voxels in V4 in that represent the same portion of retinotopically mapped space. Measured in portions of cortex representing PRL and URL. Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Other Change from Baseline Sustained Attention after Completion of Training at approximately 7 weeks Reaction time of detection of orientation of Landolt Cs presented in an RSVP stream at the beginning of each trial. Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Other Change from Baseline Endogenous Attention after Completion of Training at approximately 7 weeks Endogenous attention: reaction time when switching between locations due to an endogenous cue on valid vs nonvalid trials. Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Other Change from Baseline Exogenous Attention after Completion of Training at approximately 7 weeks Exogenous attention: reaction time when switching between locations due to an exogenous cue on valid vs. nonvalid trials. Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Other Change from Baseline Saccadic Re-referencing after Completion of Training at approximately 7 weeks Saccadic Re-referencing: number of first fixations that do not cover the target location with the scotoma. Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Other Change from Baseline Decoding classification accuracy for decoding the locus of spatial attention (PRL or URL), regardless of stimulus type after Completion of Training at approximately 7 weeks Decoding classification accuracy for decoding the locus of spatial attention (PRL or URL), regardless of stimulus type. This will be examined in frontal (FEF), parietal (SPL/IPS) and higher order visual (LOC) regions. Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Other Change from Baseline Top-down modulation of visual areas after Completion of Training at approximately 7 weeks Top-down modulation of visual areas: background connectivity between frontoparietal control regions (FEF, SPL/IPS) and visual areas ( V1, V2, V3). Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Other Change from Baseline Reading speed in the MNREAD task after Completion of Training at approximately 7 weeks Reading speed in the MNREAD task (words per minute). Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Other Change from Baseline Completion time in the trail making task after Completion of Training at approximately 7 weeks Completion time in the trail making task Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Primary Change from Baseline Radial Bias from the Crowding Task after completion of Training at approximately 7 weeks The ratio of the crowding threshold along the axis connected to the fovea vs. along the orthogonal axis. Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Primary Change from Baseline Saccadic Precision after Completion of Training at approximately 7 weeks Consistency across trials in placement of the first saccade calculated by the distribution across trials (bivariate contour ellipse area) of the landing point of the first fixation of each trial. Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
Primary Change from Baseline Fixation Stability after Completion of Training at approximately 7 weeks Normalizing fixations in the PRL to the first fixation to that region and calculating the distribution of all fixation locations in this normalized space (measured as a bivariate contour ellipse area). Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average
See also
  Status Clinical Trial Phase
Recruiting NCT06262737 - Single-center Study Measuring OSDI Dry Eye Score in Patients Undergoing an Anti-VEGF Induction Protocol
Completed NCT02540954 - Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD) Phase 3
Completed NCT00385333 - Metabolic Mapping to Measure Retinal Metabolism Phase 2
Completed NCT02510794 - Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration Phase 2
Completed NCT02390245 - Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study N/A
Completed NCT02181504 - A Study of Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration Phase 2
Terminated NCT02228304 - Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) Phase 1/Phase 2
Recruiting NCT01521065 - An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration Phase 2
Completed NCT01204541 - A Single-Center Pilot Study to Assess Macular Function N/A
Completed NCT00769392 - Pilot Study: A Randomized Trial Of Anesthetic Agents For Intravitreal Injection N/A
Withdrawn NCT00538538 - Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD) Phase 1
Completed NCT00533520 - Evaluation of Dosing Interval of Higher Doses of Ranibizumab Phase 4
Completed NCT00536016 - A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD Phase 1
Terminated NCT00403442 - Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMD Phase 1
Recruiting NCT00157976 - Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration Phase 3
Completed NCT00211458 - Treatment of Age-Related Macular Degeneration With Anecortave Acetate Phase 2
Completed NCT00242580 - A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib Phase 3
Completed NCT00239928 - Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration Phase 2
Completed NCT00095433 - Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD) Phase 3
Completed NCT00006202 - Lutein for Age-Related Macular Degeneration Phase 2